인쇄하기
취소

Pharmaceutical firms suffer dismal performance in first half

Published: 2011-08-23 07:00:00
Updated: 2011-08-23 07:00:00
Yakup.com. said that 33 drugs makers listed on the main bourse reported poor first-half performances on tough regulations and intense competition.

In the first six months of this year, these company recorded all minus growths in terms of sales (-0.9 percent), operating income (-22 percent) and net profit (-27 percent).

Dong-A Pharmaceutical saw its revenue grow 2.9 percent to 434.7 billio...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.